BioCryst Pharmaceuticals,Inc. (BCRX)

[XenaLives]

Strange:

BioCryst reports 4Q loss
2 Hours Ago
The Associated Press
DURHAM, N.C. (AP) _ BioCryst Pharmaceuticals Inc. (BCRX) on Monday reported a loss of $4.5 million in its fourth quarter.

On a per-share basis, the Durham, North Carolina-based company said it had a loss of 6 cents.

The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The drugmaker posted revenue of $9 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $4.7 million.

For the year, the company reported that its loss widened to $55.1 million, or 75 cents per share. Revenue was reported as $26.4 million.

BioCryst shares have declined 13 percent since the beginning of the year. The stock has more than doubled in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BCRX at https://www.zacks.com/ap/BCRX

Keywords: BioCryst Pharmaceuticals, Earnings Report

http://www.cnbc.com/2017/02/27/the-associated-press-biocryst-reports-4q-loss.html